Novartis AGNOVN:VTX

76.25
0.15 / 0.20%
5.43m
10.11%
0.8108
Close in CHFToday's changeShares traded1 year changeBeta
As of Apr 23 2014 16:31 BST.Data delayed by at least 15 minutes.

Summary

Novartis AG (NOVN:VTX) set a new 52-week high during today's trading session when it reached 77.10. Over this period, the share price is up 10.51%.

52-week range
Today
63.20
Jun 24 2013
77.10
Apr 23 2014
Markit short selling activity
Low
Medium
High
Open76.40
Day high77.10
Day low76.25
Bid--
Offer--
Previous close76.40
Average volume4.88m
Shares outstanding2.71bn
Free float2.51bn
P/E (TTM)23.33
Market cap206.73bn CHF
EPS (TTM)3.27 CHF
Annual div (TTM)1.59 CHF
Annual div yield (TTM)2.13%
Div ex-dateFeb 27 2014
Div pay-dateMar 04 2014
Last IC View
The last IC recommendation on Novartis AG shares was Hold at 72.25 on 26 Nov 2013
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Novartis AG+2.56%+5.10%+9.40%+10.11%+78.52%
ALL SHARE CH X INDEX+1.57%+1.80%+3.96%+10.37%+65.31%
CH/HEALTH CARE+1.62%+0.53%+6.35%+10.77%--
CH/PHARMACEUTICALS+1.63%+0.67%+5.94%+9.71%--
As of Apr 23 2014 16:31 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.